The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis (RA), exhibits anti-inflammatory, antiproliferative and immunosuppressive effects. Although most of the beneficial effects of leflunomide have been attributed to its antimetabolite activity, main...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kirsch, Bernhard M, Zeyda, Maximilian, Stuhlmeier, Karl, Grisar, Johannes, Smolen, Josef S, Watschinger, Bruno, Stulnig, Thomas M, Hörl, Walter H, Zlabinger, Gerhard J, Säemann, Marcus D
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2005
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1174963/
https://ncbi.nlm.nih.gov/pubmed/15899055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1727
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados